Promotions & Moves

Ionis Appoints Clinical Development EVP

Eugene Schneider will oversee clinical development of novel antisense medicines across all of Ionis' therapeutic franchises.

By: Contract Pharma

Contract Pharma Staff

Ionis Pharmaceuticals, Inc. has appointed Eugene Schneider, M.D., as executive vice president and chief clinical development officer. Dr. Schneider will oversee clinical development of novel antisense medicines across all of Ionis’ therapeutic franchises. He will report to Richard S. Geary, Ph.D., Ionis’ executive vice president and chief development officer, and serve on the company’s executive team.   Since joining Ionis in 2013, Dr. Schneider has played a key role in more ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters